Diffusion-Weighted Imaging of Prostate Cancer on 3T MR. Relationship between Apparent Diffusion Coefficient Values and Ki-67 Expression

Academic Radiology

Volumn 20, Issue 12, 2013, Pages 1535-1541

  Zhang, Jie ^a   Jing, Haiyan ^a   Han, Xue ^a   Huang, Zhaoqin ^a   Cao, Zhixin ^a   Liu, Qingwei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Diffusion weighted imaging; Ki 67; MR imaging; Prostate cancer

Indexed keywords

KI 67 ANTIGEN;

3T NUCLEAR MAGNETIC RESONANCE; ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE MARKER; ELECTRON SPIN RESONANCE; GLEASON SCORE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RADIOLOGICAL PARAMETERS; SIGNAL INTENSITY; TUMOR GROWTH;

DIFFUSION-WEIGHTED IMAGING; KI-67; MR IMAGING; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84887188319     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2013.09.007     Document Type: Article

References (28)

1. Davison B.J., Breckon E. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns 2012, 87:369-374.
2. Jani A.B., Hellman S. Early prostate cancer: clinical decision-making. Lancet 2003, 361:1045-1053.
3. Pollack A., DeSilvio M., Khor L.Y., et al. Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02. J Clinl Oncol 2004, 22:2133-2140.
4. Tran P.T., Hales R.K., Zeng J., et al. Tissue biomarkers for prostate cancer radiation therapy. Curr Mol Med 2012, 12:772-787.
5. Fisher G., Yang Z.H., Kudahetti S., et al. Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort. Br J Cancer 2013, 108:271-277.
6. Antonarakis E.S., Keizman D., Zhang Z., et al. An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy. Cancer 2012, 118:6063-6071.
7. Khoo V.S., Pollack A., Cowen D., et al. Relationship of Ki-67 labeling index to DNA-Ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy. Prostate 1999, 41:166-172.
8. Luczynska E., Gasinska A., Wilk W. Expression of Ki-67 (MIB-1) and GLUT-1 proteins in non-advanced prostatic cancer. Pol J Pathol 2012, 63:272-277.
9. Fütterer J.J. MR imaging in local staging of prostate cancer. Eur J Radiol 2007, 63:328-334.
10. Haider M.A., van der Kwast T.H., Tanguay J., et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007, 189:323-328.
11. Kobus T., Vos P.C., Hambrock T., et al. Prostate cancer aggressiveness: invivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. Radiology 2012, 265:457-467.
12. Wu L.M., Xu J.R., Gu H.Y., et al. Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer. Acad Radiol 2012, 19:1215-1224.
13. Woodfield C.A., Tung G.A., Grand D.J., et al. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. AJR Am J Roentgenol 2010, 194:W316-W322.
14. Hambrock T., Somford D.M., Huisman H.J., et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011, 259:453-461.
15. Vargas H.A., Akin O., Franiel T., et al. Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 2011, 259:775-784.
16. Scheenen T.W., Heijmink S.W., Roell S.A., et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology 2007, 245:507-516.
17. Li R., Heydon K., Hammond M.E., et al. Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in Radiation Therapy Oncology Group Protocol 86-10. Clin Cancer Res 2004, 10:4118-4124.
18. Wang X.Z., Wang B., Gao Z.Q., et al. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging 2009, 29:1360-1366.
19. Taftachi R., Ayhan A., Ekici S., et al. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67. BJU Int 2005, 95:650-654.
20. Wang X.Z., Wang B., Gao Z.Q., et al. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation. Eur J Radiol 2010, 73:345-351.
21. Shukla-Dave A., Hricak H., Ishill N.M., et al. Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phosphor-Akt, and androgen receptor expression in prostate cancer. Radiology 2009, 250:803-812.
22. Le Bihan D. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 1995, 8:375-386.
23. Huang H., Wylie J.J., Miura R.M. Restricted diffusion in cellular median: (1+1)-dimensional model. Bull Math Biol 2011, 73:1682-1694.
24. Zhong W., Peng J., He H., et al. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. Clin Invest Med 2008, 31:E8-E15.
25. Nikoleishvili D., Pertia A., Trsintsadze O., et al. Expression of p27((Kip1)), cyclin D3 and Ki67 in BPH, prostate cancer and hormone-treated prostate cancer cells. Int Urol Nephrol 2008, 40:953-959.
26. Langer D.L., van der Kwanst T.H., Evans A.J., et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology 2010, 255:485-494.
27. Husband J.E., Padhani A.R., MacVicar A.D., et al. Magnetic resonance imaging of prostate cancer: comparison of image quality using endorectal and pelvic phased array coils. Clin Radiol 1998, 53:673-681.
28. Shimizu T., Nishie A., Ro T., et al. Prostate cancer detection: the value of performing an MRI before a biopsy. Acta Radiol 2009, 50:1080-1088.